Mitsubishi UFJ Asset Management Co. Ltd. Has $90.08 Million Holdings in Kenvue Inc. $KVUE

Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in Kenvue Inc. (NYSE:KVUE) by 5.9% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,303,956 shares of the company’s stock after acquiring an additional 240,596 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 0.22% of Kenvue worth $90,082,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in KVUE. Vanguard Group Inc. raised its stake in Kenvue by 4.9% during the 1st quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company’s stock valued at $5,494,882,000 after purchasing an additional 10,600,682 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in shares of Kenvue by 2.5% during the first quarter. Charles Schwab Investment Management Inc. now owns 25,606,238 shares of the company’s stock valued at $613,882,000 after buying an additional 633,461 shares in the last quarter. Boston Partners raised its position in Kenvue by 7.4% during the first quarter. Boston Partners now owns 25,346,453 shares of the company’s stock valued at $606,920,000 after buying an additional 1,750,490 shares during the period. JPMorgan Chase & Co. lifted its stake in Kenvue by 11.6% in the 1st quarter. JPMorgan Chase & Co. now owns 24,912,226 shares of the company’s stock worth $597,395,000 after acquiring an additional 2,597,920 shares in the last quarter. Finally, American Century Companies Inc. boosted its position in Kenvue by 15.7% during the 1st quarter. American Century Companies Inc. now owns 21,828,854 shares of the company’s stock worth $523,456,000 after acquiring an additional 2,961,716 shares during the period. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have weighed in on KVUE. The Goldman Sachs Group lowered their target price on Kenvue from $22.00 to $19.00 and set a “neutral” rating on the stock in a research note on Thursday, October 2nd. JPMorgan Chase & Co. lowered their price objective on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a research report on Friday, October 10th. Barclays cut their target price on shares of Kenvue from $20.00 to $17.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 1st. Weiss Ratings reissued a “hold (c-)” rating on shares of Kenvue in a research note on Tuesday, October 14th. Finally, Redburn Partners set a $22.00 price target on shares of Kenvue in a report on Friday, September 26th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, twelve have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $20.17.

Kenvue Price Performance

NYSE KVUE opened at $16.90 on Monday. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $32.37 billion, a PE ratio of 22.53, a price-to-earnings-growth ratio of 2.46 and a beta of 0.71. The company has a 50 day moving average price of $16.76 and a two-hundred day moving average price of $20.26. Kenvue Inc. has a 12-month low of $14.02 and a 12-month high of $25.17.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Monday, November 3rd. The company reported $0.28 EPS for the quarter, topping the consensus estimate of $0.27 by $0.01. The company had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.83 billion. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. Kenvue’s quarterly revenue was down 3.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.28 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th will be given a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 4.9%. The ex-dividend date of this dividend is Wednesday, November 12th. Kenvue’s dividend payout ratio is presently 110.67%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.